title: Recombinant urate oxidase (rasburicase): a new targeted therapy for prophylaxis and treatment of patients with hematologic malignancies at risk of tumor lysis syndrome.
authors.affiliation: Department of Pediatrics, Columbia University, New York, NY, USA.
authors.forename: Mitchell S
authors.initials: MS
authors.lastname: Cairo
mesh_terms: D002986:Clinical Trials as Topic; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000150:complications / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012307:Risk Factors; D015275:Tumor Lysis Syndrome / Q000188:drug therapy* / Q000209:etiology; D014503:Urate Oxidase / Q000627:therapeutic use*
chemical_list: D011994:Recombinant Proteins; C469709:rasburicase; D014503:Urate Oxidase